Milica Pesic
机构: Institute for Biological Research "Sinisa Stankovic" - National Institute of Republic of Serbia
每年引用次数
引用次数
引用: 2,708
H-指数: 31
I10-指数 : 74
出版物: 200
8-Cl-cAMP and tiazofurin affect vascular endothelial growth factor production and glial fibrillary acidic protein expression in human glioblastoma cells.
Ksenija Drabek , Milica Pešic´ , Vesna Piperski , Sabera Ruždijic´
Anti-Cancer Drugs 11 ( 9) 765 -770
9
2000
Uporedna analiza ekspresije angiogenih faktora i CD44 gena u humanim ćelijskim linijama glioma i neuroblastoma in vitro
Dragana Janković , Ana Stojković , Milica S Pešić , Selma D Kanazir
Jugoslovenska medicinska biohemija 23 ( 1) 19 -24
2004
In vitro biomimetic models for glioblastoma-a promising tool for drug response studies.
Miodrag Dragoj , Victor M. Pérez-García , Tijana Stanković , Luis Fernández
Drug Resistance Updates 55 100753 -100753
23
2021
Nano-Motion Analysis for Rapid and Label Free Assessing of Cancer Cell Sensitivity to Chemotherapeutics.
Ana Podolski-Renić , Miodrag Dragoj , Sandor Kasas , Petar Stupar
Medicina-buenos Aires 57 ( 5) 446
2021
Potential of Teucrium chamaedrys L. to modulate apoptosis and biotransformation in colorectal carcinoma cells
Milena G. Milutinović , Vuk M. Maksimović , Danijela M. Cvetković , Danijela D. Nikodijević
Journal of Ethnopharmacology 240 111951
11
2019
Potential of the dual mTOR kinase inhibitor AZD2014 to overcome paclitaxel resistance in anaplastic thyroid carcinoma.
Zorica Milošević , Jasna Banković , Jelena Dinić , Chrisiida Tsimplouli
Cellular Oncology 41 ( 4) 409 -426
9
2018
Protoflavone-Chalcone Hybrids Exhibit Enhanced Antitumor Action through Modulating Redox Balance, Depolarizing the Mitochondrial Membrane, and Inhibiting ATR-Dependent Signaling.
Ahmed Dhahir Latif , Tamás Jernei , Ana Podolski-Renić , Ching-Ying Kuo
Antioxidants 9 ( 6) 519
1
2020
DTA0100, Dual Topoisomerase II and Microtubule Inhibitor, Evades Paclitaxel Resistance in P-glycoprotein Overexpressing Cancer Cells
Ana Podolski-Renić , Jasna Banković , Jelena Dinić , Carla Ríos-Luci
European Journal of Pharmaceutical Sciences 105 159 -168
19
2017
Sulfocoumarins, specific carbonic anhydrase IX and XII inhibitors, interact with cancer multidrug resistant phenotype through pH regulation and reverse P-glycoprotein mediated resistance
Ana Podolski-Renić , Jelena Dinić , Tijana Stanković , Mirna Jovanović
European Journal of Pharmaceutical Sciences 138 105012
15
2019
Modulation of Antioxidant Potential with Coenzyme Q10 Suppressed Invasion of Temozolomide-Resistant Rat Glioma In Vitro and In Vivo
Sonja Stojković Burić , Ana Podolski-Renić , Jelena Dinić , Tijana Stanković
Oxidative Medicine and Cellular Longevity 2019 3061607
16
2019
Novel TrxR1 Inhibitors Show Potential for Glioma Treatment by Suppressing the Invasion and Sensitizing Glioma Cells to Chemotherapy.
Mirna Jovanović , Miodrag Dragoj , Daniil Zhukovsky , Dmitry Dar’in
Frontiers in Molecular Biosciences 7 586146
3
2020
Purine nucleoside analog--sulfinosine modulates diverse mechanisms of cancer progression in multi-drug resistant cancer cell lines.
Ljubisav Rakić , Sabera Ruždijić , Milica Pešić , Mirjana Dačević
PLOS ONE 8 ( 1)
12
2013
Transfer of Drug Resistance Characteristics Between Cancer Cell Subpopulations: A Study Using Simple Mathematical Models
María Rosa Durán , Ana Podolski-Renić , Arturo Álvarez-Arenas , Jelena Dinić
Bulletin of Mathematical Biology 78 ( 6) 1218 -1237
7
2016
Purine nucleoside analogs in the therapy of cancer and neuroinflammation
Danijela Savić , Tijana Stanković , Irena Lavrnja , Ana Podolski-Renić
Molecular inhibitors in targeted therapy 1 ( 1)
2
2015
Synthesis, characterization and cytotoxicity of a new palladium(II) complex with a coumarin-derived ligand. Crystal structure of 4-hydroxy-3-(1-(p-tolylimino)ethyl)-2H-chromen-2-one-palladium(II) complex
Verica V. Jevtić , Milica Pešić , Gordana P. Radić , Nenad Vuković
Journal of Molecular Structure 1040 216 -220
8
2013
A New Strategy for Glioblastoma Treatment: In Vitro and In Vivo Preclinical Characterization of Si306, a Pyrazolo[3,4-d]Pyrimidine Dual Src/P-Glycoprotein Inhibitor
Anna Lucia Fallacara , Claudio Zamperini , Ana Podolski-Renić , Jelena Dinić
Cancers 11 ( 6) 848
12
2019
The role of paclitaxel in the development and treatment of multidrug resistant cancer cell lines.
Ana Podolski-Renić , Tijana Anđelković , Jasna Banković , Nikola Tanić
Biomedicine & Pharmacotherapy 65 ( 5) 345 -353
44
2011
Resistance to DNA Damaging Agents Produced Invasive Phenotype of Rat Glioma Cells—Characterization of a New in Vivo Model
Sonja Stojković , Ana Podolski-Renić , Jelena Dinić , Željko Pavković
Molecules 21 ( 7) 843
8
2016
The elimination of P-glycoprotein over-expressing cancer cells by antimicrobial cationic peptide NK-2: the unique way of multi-drug resistance modulation.
Jasna Banković , Jörg Andrä , Nataša Todorović , Ana Podolski-Renić
Experimental Cell Research 319 ( 7) 1013 -1027
22
2013
Development of resistance to antiglioma agents in rat C6 cells caused collateral sensitivity to doxorubicin.
Sonja Stojković , Ana Podolski-Renić , Jelena Dinić , Tijana Stanković
Experimental Cell Research 335 ( 2) 248 -257
24
2015
Miodrag Dragoj Mirna Jovanovic Sabera Ruzdijic Milka Jadranin Victor M. Perez-Garcia Patrícia Rijo Selma Kanazir Mikhail Krasavin Ignacio Ochoa Garrido Ivan Vuckovic José M. Padrón Aleksandar Kalauzi Egamberdieva Dilfuza Hui-Chun Wang Aleksandar Savic Miloš Mojović Branko Matovic Aleksandra Pavicevic Vesna Kojić Qing Liu